Literature DB >> 25963127

Establishment of a novel orthotopic model of breast cancer metastasis to the lung.

Wenli Guo1, Shuping Zhang2, Sijin Liu1.   

Abstract

Breast cancer is the second leading cause of cancer-related death among women, and distant metastasis is responsible for the death of ~90% of these patients. However, despite recent advances, the underlying mechanisms responsible for breast cancer metastasis remain elusive. A great impediment to this is the lack of appropriate orthotopic models of breast cancer metastasis to distant organs. In the present study, we established a novel orthotopic model of breast cancer metastasis to the lungs in mice, where metastatic sublines of 4T1 cells revealed enhanced metastatic propensity to the lungs. All mice (100%) developed lung metastasis upon orthotopic implantation of a metastatic subline of 4T1 cells, in contrast to 10% of mice with lung metastasis for a subline derived from primary tumors and 60% of mice with lung metastasis for parental 4T1 cells. At the molecular level, significant epithelial-mesenchymal transition was characterized in these metastatic sublines, which is likely at least partially, responsible for the enhanced metastasis. These established cell lines provide a novel platform to study the relevant molecular basis of metastasis and metastasis-specific therapeutics.

Entities:  

Mesh:

Year:  2015        PMID: 25963127     DOI: 10.3892/or.2015.3927

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells.

Authors:  Yoshihiro Koya; Hiroaki Kajiyama; Wenting Liu; Kiyosumi Shibata; Takeshi Senga; Fumitaka Kikkawa
Journal:  J Vis Exp       Date:  2016-12-09       Impact factor: 1.355

2.  New Approach to Non-Invasive Tumor Model Monitoring via Self-Assemble Iron Containing Protein Nanocompartments.

Authors:  Anna N Gabashvili; Maria V Efremova; Stepan S Vodopyanov; Nelly S Chmelyuk; Vera V Oda; Viktoria A Sarkisova; Maria K Leonova; Alevtina S Semkina; Anna V Ivanova; Maxim A Abakumov
Journal:  Nanomaterials (Basel)       Date:  2022-05-12       Impact factor: 5.719

3.  Role of Circulating Tumor Cell (CTC) Monitoring in Evaluating Prognosis of Triple-Negative Breast Cancer Patients in China.

Authors:  Yanwu Zhang; Yidong Lv; Yaodong Niu; Hongge Su; Aiqiang Feng
Journal:  Med Sci Monit       Date:  2017-06-23

4.  Improved Healing of Diabetic Foot Ulcer upon Oxygenation Therapeutics through Oxygen-Loading Nanoperfluorocarbon Triggered by Radial Extracorporeal Shock Wave.

Authors:  Shunhao Wang; Chunyang Yin; Xiaoguang Han; Anyi Guo; Xiaodong Chen; Sijin Liu; Yajun Liu
Journal:  Oxid Med Cell Longev       Date:  2019-08-14       Impact factor: 6.543

5.  Breast Tumor Cells Highly Resistant to Drugs Are Controlled Only by the Immune Response Induced in an Immunocompetent Mouse Model.

Authors:  Paola Lasso; Mónica Llano Murcia; Tito Alejandro Sandoval; Claudia Urueña; Alfonso Barreto; Susana Fiorentino
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

6.  Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.

Authors:  Liting Ren; Wenya Feng; Jie Shao; Juan Ma; Ming Xu; Ben-Zhan Zhu; Nanfeng Zheng; Sijin Liu
Journal:  Theranostics       Date:  2020-05-16       Impact factor: 11.556

7.  Narasin inhibits tumor metastasis and growth of ERα‑positive breast cancer cells by inactivation of the TGF‑β/SMAD3 and IL‑6/STAT3 signaling pathways.

Authors:  Jing Chen; Xieping Huang; Na Li; Boxia Liu; Zhanbing Ma; Jun Ling; Wenjun Yang; Tao Li
Journal:  Mol Med Rep       Date:  2020-10-21       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.